Pharmacogenomic testing in depression : a review of clinical effectiveness, cost-effectiveness, and guidelines /
The purpose of this report is to examine the clinical effectiveness, cost-effectiveness of pharmacogenomic testing versus treatment as usual for treating all severities of diagnosed depression. Additionally, evidence-based guidelines regarding the pharmacogenomic testing in patients with all severit...
Saved in:
| Online Access: |
Full text |
|---|---|
| Main Authors: | , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Ottawa :
Canadian Agency for Drugs and Technologies in Health,
2020
|
| Edition: | Version: 1.0. |
| Series: | Rapid response report (Canadian Agency for Drugs and Technologies in Health)
|
| Subjects: |
